IRIS
IANNUZZO, GABRIELLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 4.145
EU - Europa 3.397
NA - Nord America 2.665
SA - Sud America 637
AF - Africa 119
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 1
Totale 10.966
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.549
SG - Singapore 2.306
RU - Federazione Russa 1.727
CN - Cina 958
IT - Italia 687
BR - Brasile 509
DE - Germania 334
HK - Hong Kong 331
VN - Vietnam 308
FI - Finlandia 138
NL - Olanda 119
FR - Francia 103
GB - Regno Unito 77
AR - Argentina 56
CA - Canada 50
IN - India 47
CI - Costa d'Avorio 44
MX - Messico 44
KR - Corea 42
IE - Irlanda 38
PL - Polonia 35
ZA - Sudafrica 29
UA - Ucraina 28
AT - Austria 25
SE - Svezia 25
EC - Ecuador 24
ID - Indonesia 24
BD - Bangladesh 22
JP - Giappone 18
ES - Italia 16
VE - Venezuela 14
IQ - Iraq 12
MA - Marocco 11
CO - Colombia 10
TR - Turchia 10
PY - Paraguay 8
CL - Cile 7
KE - Kenya 7
CH - Svizzera 6
IR - Iran 6
LT - Lituania 6
NP - Nepal 6
SA - Arabia Saudita 6
UZ - Uzbekistan 6
AL - Albania 5
BG - Bulgaria 5
DZ - Algeria 5
PK - Pakistan 5
AE - Emirati Arabi Uniti 4
BE - Belgio 4
CZ - Repubblica Ceca 4
EG - Egitto 4
IL - Israele 4
NI - Nicaragua 4
PE - Perù 4
DO - Repubblica Dominicana 3
HN - Honduras 3
JO - Giordania 3
LB - Libano 3
PT - Portogallo 3
TH - Thailandia 3
UY - Uruguay 3
AZ - Azerbaigian 2
BO - Bolivia 2
CM - Camerun 2
EE - Estonia 2
GE - Georgia 2
GH - Ghana 2
GT - Guatemala 2
LY - Libia 2
MY - Malesia 2
OM - Oman 2
PH - Filippine 2
RO - Romania 2
SC - Seychelles 2
SN - Senegal 2
SY - Repubblica araba siriana 2
TW - Taiwan 2
XK - ???statistics.table.value.countryCode.XK??? 2
AM - Armenia 1
AU - Australia 1
BB - Barbados 1
BF - Burkina Faso 1
BH - Bahrain 1
BJ - Benin 1
BS - Bahamas 1
BZ - Belize 1
CR - Costa Rica 1
CY - Cipro 1
DK - Danimarca 1
DM - Dominica 1
GA - Gabon 1
GM - Gambi 1
GN - Guinea 1
HU - Ungheria 1
JM - Giamaica 1
KH - Cambogia 1
KY - Cayman, isole 1
KZ - Kazakistan 1
LC - Santa Lucia 1
Totale 10.952
Salva come PNG Salva come JPEG
Città #
Singapore 1.111
Moscow 372
Hong Kong 331
Chandler 308
Ashburn 293
Beijing 292
Hefei 262
Santa Clara 181
Munich 141
Naples 132
Ho Chi Minh City 118
Los Angeles 96
Millbury 90
Boardman 75
Helsinki 70
Amsterdam 67
Boston 67
Hanoi 55
Napoli 55
Buffalo 54
Lawrence 49
São Paulo 45
Des Moines 44
Princeton 43
Seoul 42
Rome 41
Redondo Beach 39
New York 37
Frankfurt am Main 30
Nanjing 28
Turku 27
Dallas 26
Dong Ket 26
Nuremberg 25
Wilmington 24
Jacksonville 22
Warsaw 21
Rio de Janeiro 20
Milan 19
Seattle 19
Falkenstein 18
Mexico City 18
The Dalles 17
Marsala 16
Phoenix 16
Shanghai 16
Denver 15
Hebei 15
Washington 15
Brasília 14
Lauterbourg 14
London 14
Nanchang 14
Changsha 13
Curitiba 13
Düsseldorf 13
Houston 13
Jiaxing 13
Krefeld 13
Ottawa 13
Tokyo 13
Toronto 13
Brooklyn 12
Dublin 12
Fairfield 12
Montreal 11
Stockholm 11
Xi'an 11
Atlanta 10
Biên Hòa 10
Chennai 10
Chicago 10
Da Nang 10
Guangzhou 10
Haiphong 10
Orem 10
Woodbridge 10
Augusta 9
Guayaquil 9
Lappeenranta 9
Poplar 9
Portsmouth 9
Salt Lake City 9
Shenyang 9
Tianjin 9
Vienna 9
Belo Horizonte 8
Genoa 8
Ha Long 8
Kochi 8
San Francisco 8
Bologna 7
Buenos Aires 7
Dhaka 7
Guarulhos 7
Johannesburg 7
Kronberg 7
Manchester 7
Nairobi 7
Nocera Inferiore 7
Totale 5.459
Salva come PNG Salva come JPEG
Nome #
Short-term treatment of iron deficiency anemia after cardiac surgery 228
Efficacy, safety, adherence and persistence of PCSK9 inhibitors in clinical practice: A single country, multicenter, observational study (AT-TARGET-IT) 219
Dyslipidemia in Transplant Patients: Which Therapy? 174
Atherogenic Lipoprotein Subfractions and Carotid Atherosclerosis in Menopausal Women 120
Apo B, Small-dense LDL and carotid atherosclerosis in menopausal women 119
A wide next-generation-sequencing panel improves the molecular diagnosis of dyslipidemias 119
Predictive and prognostic markers in a cohort of Mediterranean women:review from Atena project 115
Efficacy and Safety of Bempedoic Acid in Patients With Hypercholesterolemia: Systematic Review and Meta-Analysis of Randomized Controlled Trials 115
Efficacy and safety of lomitapide in homozygous familial hypercholesterolaemia: the pan-European retrospective observational study 114
Association between small dense LDL and sub-clinical atherosclerosis in patients with psoriatic arthritis 113
Effects of Bisphosphonate Treatment on Circulating Lipid and Glucose Levels in Patients with Metabolic Bone Disorders 113
Efficacy of Long-Term Treatment of Autosomal Recessive Hypercholesterolemia With Lomitapide: A Subanalysis of the Pan-European Lomitapide Study 112
Association between small dense LDL and early atherosclerosis in a sample of menopausal women. 111
Iodine Requirements in Pediatrics: From Fetal Life to Adolescence 110
Causative mutations and premature cardiovascular disease in patients with heterozygous familial hypercholesterolaemia 109
Lipoprotein(A) where do we stand? from the physiopathology to innovative terapy 109
Lipoprotein(a) Genotype Influences the Clinical Diagnosis of Familial Hypercholesterolemia 107
Aterosclerosi preclinica 106
New Ultrasound Technologies for Ischemic Heart Disease Assessment and Monitoring in Cardiac Rehabilitation 106
Genetic spectrum of familial hypercholesterolemia and correlations with clinical expression: Implications for diagnosis improvement 106
Association between causative mutations and response to PCSK9 inhibitor therapy in subjects with familial hypercholesterolemia: A single center real-world study 106
Association between small dense LDL particles and early atherosclerosis in a sample of middle-aged women. Findings from Progetto Atena 105
Case Report: Genetic Analysis of PEG-Asparaginase Induced Severe Hypertriglyceridemia in an Adult With Acute Lymphoblastic Leukaemia 105
Association between Non-HDL-C/HDL-C Ratio and Carotid Intima-Media Thickness in Post-Menopausal Women. 105
Association between Lp (a) and atherosclerosis in menopausal women without metabolic syndrome. 104
Homozygous familial hypercholesterolemia in Italy: Clinical and molecular features. 104
Association between Very Low-Density Lipoprotein Cholesterol (VLDL-C) and Carotid Intima-Media Thickness in Postmenopausal Women Without Overt Cardiovascular Disease and on LDL-C Target Levels. 103
Sex Differences in Diagnosis, Treatment, and Cardiovascular Outcomes in Homozygous Familial Hypercholesterolemia 102
Efficacy and safety of lomitapide in familial chylomicronaemia syndrome 102
Authors’ response to letter by Sbrana et al. “Evolocumab improve intima media thickness regression in He-FH subjects on lipoprotein apheresis” 102
Efficacy and safety of direct oral anticoagulants in splanchnic vein thrombosis: a pooled analysis of literature studies 100
Renal involvement in COVID-19: focus on kidney transplant sector 100
Sex-related differences in response to lomitapide in HoFH: A subanalysis of the Pan-European Lomitapide retrospective observational study 99
Creatinine levels and intima media thickness in a population based cohort study: finding from Progetto Atena. 99
Frailty in Acute and Chronic Coronary Syndrome Patients Entering Cardiac Rehabilitation 99
Idiopathic Osteoporosis and Nephrolithiasis: Two Sides of the Same Coin? 97
Association of apolipoprotein levels with peripheral arterial disease: a meta-analysis of literature studies 97
The Role of Registers in Increasing Knowledge and Improving Management of Children and Adolescents Affected by Familial Hypercholesterolemia: the LIPIGEN Pediatric Group 96
Association between small dense ldl and cardiovascular events in Familial combined hyperlipidemia. 95
Effects of weight modification on hs-crp in a cohort of mediterranean women: findings from progetto atena. 95
ipotiroidismo subclinico ed aterosclerosi carotidea 95
More inflammation in Familial Hypercholesterolemia than in Familial Combined Hyperlipidemia. 94
Association between body shape index and small dense LDL particles in a cohort of mediterranean women: Findings from Progetto ATENA 94
A Real-World Experience of Clinical, Biochemical and Genetic Assessment of Patients with Homozygous Familial Hypercholesterolemia 94
Assessment of Platelet Aggregation and Thrombin Generation in Patients with Familial Chylomicronemia Syndrome Treated with Volanesorsen: A Cross-Sectional Study 93
Impaired endothelium-dependent vascular reactivity in patients with familial combined hyperlipidaemia. 93
Screening for Familial Combined Hyperlipidemia criteria in a cohort of Mediterranean women: findings from Progetto ATENA 93
Società per lo studio dell'aterosclerosi ( Sezione Campania) 93
Cardiovascular disease and antiphospholipid syndrome: how to predict and how to treat? 93
Carotid Atherosclerosis, Ultrasound and Lipoproteins 93
Exercise Training in Patients with Heart Failure: From Pathophysiology to Exercise Prescription 93
Venous thromboembolism and major bleeding in severe and critical COVID-19 hospitalized patients 93
Association of systemic lupus erythematosus with peripheral arterial disease: a meta-analysis of literature studies 92
Inflammatory markers in Familial Combined Hyperlipidemia 91
Association between Lp(a) and small dense LDL in menopausal women without metabolic syndrome 91
SMALL DENSE LDL IN RELATION TO CHANGES IN OXIDATION MARKERS AND VASCULAR REACTIVITYIN PATIENTS WITH HYPERCHOLESTEROLEMIA TREATED WITH EVOLOCUMAB: A PROSPECTIVE COHORT STUDY 91
Fat mass and vascular health in overweight/obese children 91
High endogenous estradiol is associated with increased venous distensibility and clinical evidence of varicose veins in menopausal women. 90
Pathophysiological Role of Synovitis in Hemophilic Arthropathy Development: A Two-Hit Hypothesis 90
Endothelial function improvement in patients with familial hypercholesterolemia receiving PCSK-9 inhibitors on top of maximally tolerated lipid lowering therapy 90
Long-term hepatic safety of lomitapide in homozygous familial hypercholesterolaemia 90
Exercise Training in Elderly Cancer Patients: A Systematic Review 89
Changes in carotid stiffness in patients with familial hypercholesterolemia treated with Evolocumab®: A prospective cohort study 89
EVOLOCUMAB IS EFFECTIVE AND SAFE TO TREAT HYPERCHOLESTEROLEMIA IN A PATIENT WITH STATIN-INDUCED NECROTIZING MYOPATHY 88
The bone-heart axis in the pathogenesis of cardiovascular diseases: A narrative review 87
Tumor necrosis factor-α is a marker of familial combined hyperlipidemia, independently of metabolic syndrome 87
Early carotid atherosclerosis in obesity and overweight is independent of hs-CRP in a cohort of mediterranean women: findings from Progetto Atena 87
Changes in markers of subclinical atherosclerosis in patients with familial hypercholesterolemia treated with evolocumab: a prospective cohort study 86
[How to overcome barriers to implementation of prevention and management strategies of atherosclerotic cardiovascular disease through lipid-lowering therapy] 86
Familial Combined hyperlipidemia and IMT 86
The relationship between BMI and common carotid plaques or Apo B and bifurcation plaques are independent of hs-CPR concentration: findings from Progetto ATENA 86
Biochemical Screening for Familial Combined Hyperlipidemia 86
Long-term efficacy of lipoprotein apheresis and lomitapide in the treatment of homozygous familial hypercholesterolemia (HoFH): a cross-national retrospective survey 86
Impact of 12-SNP and 6-SNP Polygenic Scores on Predisposition to High LDL-Cholesterol Levels in Patients with Familial Hypercholesterolemia 85
Lipoprotein (a) is an independent predictor of cardiovascular events in Mediterranean women (Progetto Atena) 85
Sacubitril/Valsartan Improves Autonomic Function and Cardiopulmonary Parameters in Patients with Heart Failure with Reduced Ejection Fraction 85
Small dense low-density lipoprotein in familial combined hyperlipidemia: Independent of metabolic syndrome and related to history of cardiovascular events. 85
Contemporary lipid-lowering management and risk of cardiovascular events in homozygous familial hypercholesterolaemia: insights from the Italian LIPIGEN Registry 85
Tumor Necrosis Factor-α is a marker of Familial Conbined Hyperlipidemia, independently of metabolic sindrome 84
Clinical Evidence for Q10 Coenzyme Supplementation in Heart Failure: From Energetics to Functional Improvement 84
Relation of body mass index with carotid intima-media thickness and diameter is independent of metabolic syndrome in postmenopausal Mediterranean women. 83
Exercise for slowing the progression of atherosclerotic process: effects on inflammatory markers 83
Inhibitors of Protein Convertase Subtilisin/Kexin 9 (PCSK9) and Acute Coronary Syndrome (ACS): The State-of-the-Art 83
Oltre le statine quale terapia per l'ipercolesterolemia: gli inibitori del pCSK9 e l'inclisiran 82
Twelve Variants Polygenic Score for Low-Density Lipoprotein Cholesterol Distribution in a Large Cohort of Patients With Clinically Diagnosed Familial Hypercholesterolemia With or Without Causative Mutations 82
Refinement of the diagnostic approach for the identification of children and adolescents affected by familial hypercholesterolemia: Evidence from the LIPIGEN study 81
Effects of short-term reduction in serum cholesterol with simvastatin in patients with stable angina pectoris and mild to moderate hypercholesterolemia 81
Carotid artery wall hypertrophy in children with metabolic syndrome 80
Aterosclerosi subclinica. influenza dei geni e dell' ambiente 80
A height-weight formula to measure body fat in childhood obesity 79
Diagnosis and Screening Strategies for Detection of Familial Hypercholesterolaemia in Children and Adolescents in Italy: A Survey from the LIPIGEN Paediatric Group 78
Evinacumab for Homozygous Familial Hypercholesterolemia: The Italian Cohort of the ELIPSE HoFH Study 78
Relation of body mass index with intima media thickness and diameters is independent of metabolic syndrome in post menopausal women. 78
Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors Use for Atherogenic Dyslipidemia in Solid Organ Transplant Patients 77
Oncology and Cardiac Rehabilitation: An Underrated Relationship 75
The association between overweight/obesity with early signs of atherosclerosis is independent of insulin resistance (HOMA INDEX) and inflammation (HS-CRP). 74
Haematological Drugs Affecting Lipid Metabolism and Vascular Health 73
Comparison of two diets of varying glycemic index on carotid subclinical atherosclerosis in obese children. 73
Evinacumab for Homozygous Familial Hypercholesterolemia 72
INIBITORI DI PCSK9 : ESPERTI A CONFRONTO G. Iannuzzo: L’esperto di ultrasuoni 71
Totale 9.676
Salva come PNG Salva come JPEG
Categoria #
all - tutte 36.691
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 36.691
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021150 0 0 0 0 0 38 16 10 9 3 40 34
2021/2022527 7 9 7 6 17 3 3 31 22 78 135 209
2022/2023807 97 57 37 46 96 85 5 81 113 71 93 26
2023/2024774 65 91 53 43 47 84 11 94 21 38 120 107
2024/20254.083 182 146 44 102 82 283 444 277 256 493 1.452 322
2025/20264.363 791 617 806 709 1.271 169 0 0 0 0 0 0
Totale 11.184